Elias Fattal is a professor in Drug Delivery Science at the University of Paris-Saclay in Orsay, France, and has been President of APGI from 2003 to 2010. He received his Pharmacy Degree (1983) and Ph.D. (1990) from the University of Paris-Sud and followed an internship in Hospital Pharmacy at the University of Lille (1984-1986). After visiting the Department of Pharmaceutical Chemistry at the University of California, San Francisco for a post-doctoral position (1990-1991), he became an Associate Professor (1992) and a full Professor at the University of Paris-Saclay (2000). He has been the head of the Institut Galien Paris-Saclay (2010-2019). Over the past 35 years, he has made fundamental and applied contributions to the fields of drug delivery using nanotechnologies for targeted or local delivery of drugs and nucleic acids. He has recently focused on lung nanotoxicity, as well as the design of nanoparticle-based delivery systems for the delivery of anti-inflammatory drugs and nucleic acids. He has contributed to approximately 330 publications and book chapters, as well as 14 patents. Prof. Fattal has received the Pharmaceutical Sciences World Congress (PSWC) Research Achievement Award (2007) and the Controlled Release Society Fellow Award (2016). He was also awarded by the French Academy of Sciences in 2016 for his research at the interface of chemistry and biology. In 2018, he received the Maurice-Marie Janot Award. He serves on the editorial board of several scientific journals and is a member of the National Academy of Pharmacy, the National Academy of Medicine and the European Academy of Sciences.Home
Elias Fattal is a professor in Drug Delivery Science at the University of Paris-Saclay in Orsay, France, and has been President of APGI from 2003 to 2010. He received his Pharmacy Degree (1983) and Ph.D. (1990) from the University of Paris-Sud and followed an internship in Hospital Pharmacy at the University of Lille (1984-1986). After visiting the Department of Pharmaceutical Chemistry at the University of California, San Francisco for a post-doctoral position (1990-1991), he became an Associate Professor (1992) and a full Professor at the University of Paris-Saclay (2000). He has been the head of the Institut Galien Paris-Saclay (2010-2019). Over the past 35 years, he has made fundamental and applied contributions to the fields of drug delivery using nanotechnologies for targeted or local delivery of drugs and nucleic acids. He has recently focused on lung nanotoxicity, as well as the design of nanoparticle-based delivery systems for the delivery of anti-inflammatory drugs and nucleic acids. He has contributed to approximately 330 publications and book chapters, as well as 14 patents. Prof. Fattal has received the Pharmaceutical Sciences World Congress (PSWC) Research Achievement Award (2007) and the Controlled Release Society Fellow Award (2016). He was also awarded by the French Academy of Sciences in 2016 for his research at the interface of chemistry and biology. In 2018, he received the Maurice-Marie Janot Award. He serves on the editorial board of several scientific journals and is a member of the National Academy of Pharmacy, the National Academy of Medicine and the European Academy of Sciences.
